The future of bioprocessing across Asia Pacific May 14th, 2024 The APAC bioprocessing market was one of the best performing sectors between 2022-2023—growing at about 18% annually—driven by pandemic spending. However, with post-pandemic normalisation and increased cost of financing, this has dropped to a flatline between 2022-2023. Campaign Life sciencesAsia
Orthopaedics robotics in Asia Pacific May 8th, 2024 Joint robotics sees the highest penetration in knee while hip is an emerging segment Knee and hip procedures are growing across APAC Robotic installations are increasing year-on-year Clearstate Insights Orthopaedic & Spine SurgeryRobotic surgerySurgical deviceAsiaGlobalSurgical Gateway
Disease trends in Vietnam March 21st, 2024 Vietnam’s population will continue to grow during 2018-2027. We project an annual average increase of 0.6% in 2023-27, to more than 100m by the end of the forecast period. Clearstate Insights Disease TrendsIn-vitro diagnosticsInfectious Diseases Testing MonitorGlobalVietnamIVD Gateway
「外科手術のDX推進を後押しする6つの要因」のダウンロード March 14th, 2024 「外科手術のDX推進を後押しする6つの要因」の無料インフォグラフィックにリクエストいただきありがとうございます。 Campaign Asia
外科手術のDX推進を後押しする6つの要因 March 14th, 2024 デジタルヘルステクノロジーは、世界中の外科手術を変革しています。手術ロボット、人工知能(AI)、5Gを活用し遠隔手術のようなテクノロジーは、外科治療の提供における課題を解決し、より精密で先進的な治療法に対する患者の要求に応えていきます。 Campaign General surgerySurgical deviceAsia
政府の施策が中国の手術ロボット市場に及ぼす影響 March 13th, 2024 政府によるデジタル医療推進の流れを受け、中国における手術ロボットの導入は今後加速する可能性が高い。“次世代AI産業”の推進を謳い2018年に開始された『3カ年行動計画』は、手術ロボットのニーズ拡大を受けたものだ。 Clearstate Insights China Segmentation Surgical Devices TrackerGeneral surgeryRobotic surgerySurgical deviceAsiaChina Segmentation Surgical Devices TrackerGeneral SurgeryRobotic surgerySurgical Gateway
政府の施策が韓国の手術ロボット市場に及ぼす影響 March 13th, 2024 韓国では、医療産業における長期的成長の牽引役として、デジタル技術の重要性が高まっている。パンデミック後に発表された韓国版『ニューディール』構想では、2025年までの経済開発関連費として1300億ドルを超える予算が盛り込まれた。重点医療分野でのロボティクス活用といったデジタル医療の推進策を含む『デジタル・ニューディール』も、その一環として重視されている。 Clearstate Insights General surgeryRobotic surgerySurgical deviceAsiaGeneral SurgeryRobotic surgerySurgical Gateway
Disease trends in China February 14th, 2024 China’s population has reached its peak and is projected to remain above 1.39bn until 2035. After a brief rebound, the number of newborns is expected to return to its previous downward trend owing to a combination of fewer women of reproductive age and declining fertility rates. Clearstate Insights Disease TrendsIn-vitro diagnosticsInfectious Diseases Testing MonitorAsiaInfectious Diseases Testing MonitorIVD Gateway
China’s IVD market – sample report February 7th, 2024 China has been aggressively implementing various policies to control healthcare costs. In recent years, volume-based procurement (VBP) has been one of the most impactful policies, significantly reshaping China’s IVD market landscape. Campaign In-vitro diagnosticsPoint-of-care testing (POCT)Segment Trend Report samplesAsia
Segment Trend Report sample for China – Thank you February 7th, 2024 Segment Trend Report sample report for China: Thank you Campaign Uncategorised
Thailand’s IVD market – sample report February 7th, 2024 The Centralised Diagnostics (CDx) market in Thailand experienced an overall growth of 10.7% from 2021 to 2022, as the market began its recovery from the COVID-19 pandemic, emerging as the leading contributor to the overall IVD market at the end of this period. Campaign In-vitro diagnosticsPoint-of-care testing (POCT)Segment Trend Report samplesAsia
Segment Trend Report sample for Thailand – Thank you February 7th, 2024 Segment Trend Report sample report for Thailand: Thank you Campaign Uncategorised